Aldeyra Therapeutics (ALDX) Set to Up Higher by 60% Following Positive Results from Phase 2b Dry Eye Disease Clinical Trial

September 26, 2018 7:33 AM

Aldeyra Therapeutics (NASDAQ: ALDX) Set ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found